Contact Us

Harnessing the regenerative power of fat,

The largest source of stem cells.

Harnessing the unlimited power of fat,

The largest source of regenerative cells.

Sayenza Biosciences

Sayenza Bio is a leading clinical stage biotechnology company committed to improving patient lives by harnessing the regenerative power of fat, the body’s largest source of regenerative cells, for limitless aesthetic and regenerative medicine applications.

At Sayenza, our passionate, doctor-driven team unites cutting-edge scientific innovation with vast commercial expertise, propelling us towards transformative breakthroughs in healthcare.

THE POWER OF “LIQUID GOLD”

LIPOSUCTION

#1 procedure performed by plastic surgeons

CONVENTIONAL FAT PROCESSING
Standard processing in aesthetic procedures
Face Contouring

Face Contouring

Fat, a healthier alternative to artificial fillers, is projected to tap into a market valued at $9B by 2028.

Breast Contouring

Breast Contouring

Fat, as a natural alternative to breast implants, is poised to disrupt a market expected to hit $4B by 2028.

Butt Lift

Butt Lift

The hottest trend, powered by social media - revenue is forecasted to reach $6.6B by 2028.

REGENERATIVE THERAPY

Emerging as powerful tool in regenerative medicine
Hair Restoration (Allopecia)

Hair Restoration

Regenerating hair follicles, providing a novel solution for Alopecia.

Myocardium Restoration (e.g. Heart Attack)

Myocardium Restoration

Repairing heart tissue post-heart attack.

Nervous System Rebuilding (e.g. SCI and TBI)

Nervous System Rebuilding

Restoring neural pathways, heralding breakthroughs in SCI and TBI treatment.

Skin Rejuvenation (e.g. Skin Aging)

Skin Rejuvenation

Revitalizing aging skin, offering a natural route to youthfulness.

Wound Healing (e.g. DFUs)

Wound Healing

Accelerating the healing of wounds, including diabetic foot ulcers.

Cartilage Repair (e.g. Osteoarthritis)

Cartilage Repair

Repairing damaged cartilage, creating new hope for osteoarthritis patients.

Management Team

derek
Derek Banyard
MD, MS, MBA
Founder
CEO
Read More
Captura de Pantalla 2023-05-30 a la(s) 15.37
Sahil
Nock
Chief Commercial Officer
Read More
jered
Jered Haun
PhD
Co-founder, Advisor

Read More
alan
Alan Widgerow
MBBCh, MMed
Co-founder, Advisor

Read More
adam
Adam
Mathis
Chief Financial
Officer (fractional)
Read More
Clinical Advisors
Business Advisors
Ethan Kellum
MD

Orthopedic Surgeon, USA Basketball Team Doctor, Former Team Doctor, Boston Celtics

Read More
Patrick Tonnard
MD, PhD

Inventor,
Nanofat Technique

Read More
Alexis Verpaele
MD, PhD

Co-inventor,
Nanofat Technique

Read More
Kwame
Ulmer
Regulatory Expert, Venture Partner
Read More
Joe
Daniels
Partner,
Co-Chair, Emerging Companies
Read More
Chuck
Larsen
Partner, Intellectual Property
Read More
Stephanie
Garth
Regulatory Affairs Consultant
Read More
Travis
Garth
Quality Assurance Consultant
Read More
Clinical Advisors
Ethan Kellum
MD

Orthopedic Surgeon, USA Basketball Team Doctor, Former Team Doctor, Boston Celtics

Read More
Patrick Tonnard
MD, PhD

Inventor,
Nanofat Technique

Read More
Alexis Verpaele
MD, PhD

Co-inventor,
Nanofat Technique

Read More
Business Advisors
Kwame
Ulmer
Regulatory Expert, Venture Partner
Read More
Joe
Daniels
Partner,
Co-Chair, Emerging Companies
Read More
Chuck
Larsen
Partner, Intellectual Property
Read More
Stephanie
Garth
Regulatory Affairs Consultant
Read More
Travis
Garth
Quality Assurance Consultant
Read More
Our Solution
Problem

Engineered for efficiency and precision, Sayenza’s automated, multifunctional device processes fat in under 15 minutes. Simultaneously, it creates a potent, ready-to-use therapeutic, for reinjection at the point of care.

Time
Consulting

Traditional fat processing can take up to 2 hours, reducing clinical efficiency.

Multistep/Manual Input

Manual, multistep procedures lead to inconsistent outcomes, compromising patient results.

Contamination
Risk

Multiple manual steps increase the chance of contamination, posing potential health risks.

Surgeon
Distraction

Labor-intensive processes divert surgeons' attention from primary patient care, impacting overall treatment quality.

Our Solution

Engineered for efficiency and precision, Sayenza’s automated, multifunctional device processes fat in under 15 minutes. Simultaneously, it creates a potent, ready-to-use therapeutic, for reinjection at the point of care.

Problem

Time
Consulting

Traditional fat processing can take up to 2 hours, reducing clinical efficiency.

Multistep/Manual Input

Manual, multistep procedures lead to inconsistent outcomes, compromising patient results.

Contamination
Risk

Multiple manual steps increase the chance of contamination, posing potential health risks.

Surgeon
Distraction

Labor-intensive processes divert surgeons' attention from primary patient care, impacting overall treatment quality.

The Science Matters
Publications

Comparable cell counts & viability. Superior enrichment of key regenerative cell populations.

*Compared to standard manual processing
Our Competition

Sayenza Bio is developing the industry’s first multi- functional automated platform that produces injectables for both fat grafting and regenerative therapy.

FAT GRAFTING

REGENERATIVE THERAPY

Method/Company
Centrifugation, decant, wick
Fully automated processing
–
–
–
–
–

Reduced OR/procedure time

–
–
–
–
–

Allows processing small & large volumes

–
–
–
–
–

Reusable platform

–
–
–
Power-assisted fat reinjection
–
–
–
–
–

Activated Regenerative  Cell Therapeutic

–
–
–
–
–
Our Competition
Sayenza Bio is developing the industry’s first multi- functional automated platform that produces injectables for both fat grafting and cell therapy.

Backed by:

Recognition & Partners Supporting our work:
sayenza-logos
sayenza-logos2

“I am thrilled to join the board at Sayenza, a company that shares my passion for pioneering breakthroughs in regenerative medicine. Their dedication to harnessing the incredible potential of adipose-derived regenerative cells aligns perfectly with my own clinical expertise and commitment to transforming patient care. I believe that together, we can shape the future of regenerative therapies and create lasting, positive impacts on the lives of countless individuals.”

Dr. Ethan Kellum

Sports Medicine Orthopedic Surgeon
Nashville Regenerative Orthopedics
Former Assistant Team Physician for the Boston Celtics Clinical Advisory Board Member at Sayenza Biosciences

“We are thrilled to join the visionary team at Sayenza Biosciences, a company that is revolutionizing aesthetics and regenerative healthcare. We have spent our careers exploring the extraordinary potential of nanofat, and to see it being harnessed and magnified in such an innovative way is incredibly gratifying. It’s a new dawn in the field of regenerative medicine, and we are proud to be a part of this evolution, pushing the boundaries of what is possible.”

Drs. Patrick Tonnard and Alexis Verpaele

Co-inventors of nanofat

Get In Touch With Us Today

For  any inquiries or information regarding our innovative regenerative medicine technologies, please contact us through the provided form or email.

Facebook-f Twitter Linkedin

Blog & News

Derek Banyard
MD, MS, MBA

Founder, CEO

Linkedin Twitter

Dr. Banyard is a surgeon and internationally acclaimed adipose stem cell researcher. He left plastic surgery residency to found Sayenza Biosciences and has been recognized with several grants and awards. He is former chief scientist at the Center for Tissue Engineering at UC Irvine where his early research earned him a coveted Regenerative Medicine Training grant from the California Institute for Regenerative Medicine as well as the National Endowment for Plastic Surgery grant from the Plastic Surgery Foundation. He has co-authored over 100 abstracts, posters, and publications.

Sahil Nock
Chief Commercial Officer
Linkedin

Sahil is an award winning commercial leader with $2B+ in revenue generated at biotech’s most iconic brands. He is responsible for the FreeStyle Libre  launch at Abbott which is recognized as a top medical device launch He has helped raised over $17M in funding for a Nasdaq company and was formally commercial marketing lead for Mentor, J&J’s Aesthetic Business, with deep understanding of the market.

Jered Haun
PhD
Co-founder, Engineering Consultant
Linkedin

Dr. Haun is an Associate Professor of Biomedical Engineering and a member of the Chao Family Comprehensive Cancer Center and Center for Advanced Design and Manufacturing of Integrated Microfluidics at UC Irvine. Professor Haun is an expert in tissue processing and microfluidics and a previous Chan Zuckerberg Grant recipient.

Alan Widgerow
MBBCh, MMed

Co-founder, Clinical Consultant

Linkedin

Dr. Widgerow is professor of plastic surgery and director of the Center for Tissue Engineering in the Department of Plastic Surgery at UC Irvine. He has over 20 years of experience as a private practice plastic surgeon and has authored over 15 patents and 200 abstracts, posters, and publications. He has been involved in several businesses and startups, and currently serves as chief medical officer at Alastin Skincare, the fastest growing professional skincare brand in the U.S., which was recently acquired by Galderma making Dr. Widgerown Chief Scientific Officer and Head of Skin Science Center of Innovation at Galderma.

Adam Mathis
Chief Financial Officer (fractional)
Linkedin

Adam has broad-based experience in leading accounting and finance teams for small to mid-size companies. He has proven successes in capitalizing on strategic opportunities through mergers, acquisitions, divestitures and financing transactions in biotech and pharma.

Contact Us
Ethan Kellum
M.D.
Orthopedic Surgeon, Former Asst. Team Doctor, Boston Celtics
Linkedin Twitter Youtube

Dr. Kellum is owner and principal at Nashville Regenerative Orthopedics and the Kellum Stem Cell Institute. He is a sports medicine fellowshipped trained orthopedic surgeon specializing in musculoskeletal injuries and joint conditions. He is a former team doctor for the Boston Celtics and a current team doctor for USA Basketball.

Patrick Tonnard
MD, PhD
Inventor, Nanofat Technique.

Dr. Tonnard is Inventor of the revolutionary Nanofat Technique. He is co-founder at the Coupure Centre for Plastic Surgery and Aesthetic Medical Centre 2 and is also co-founder of the VZW See & Smile non-profit organization.

Alexis Verpaele
MD, PhD
Co-inventor, Nanofat Technique.
Linkedin

Dr. Verpaele is co-inventor of the revolutionary Nanofat Technique. He is Founder at the Coupure Centre for Plastic Surgery and Aesthetic Medical Centre 2 and is also co-founder of the VZW See & Smile non-profit organization. He is the immediate Past-President of the Royal Belgian Society for Plastic Surgery.

Kwame Ulmer

Advisor

Linkedin

Kwame is managing partner at MedTech Impact Partners, venture partner at Wavemaker Three-Sixty Health, and founder and executive director at MedTech Color.  He brings twenty years of experience evaluating medical technologies in the government and private sector, and serving in senior operating roles at medical device companies. He has personally evaluated more than 1,000 medical technologies in his career. Kwame spent 12 years at the U.S. Food and Drug Administration (FDA) in progressive leadership roles, including Deputy Director and Branch Chief. He also served as Vice President, Regulatory Affairs and Quality Assurance at Implant Direct, a Danaher Corporation operating company.

Joe Daniels

Partner, Co-Chair, Emerging Companies

Linkedin

Joe is Partner and co-chair, emerging companies at Nelson Mullins Riley & Scarborough. He has extensive experience in life science and consumer companies, venture capital and private equity funds and investment banks in a wide range of seed and venture financings, mergers and acquisitions, IPOs and other public offerings.

Chuck Larsen
Partner, Intellectual Property
Linkedin

Chuck is Partner at McDermott Will & Emery LLP. He provides strategic patent advocacy in U.S. and European disputes, and strategic global counseling, prosecution, due diligence and transaction advice. He is one of very few who has prosecuted and litigated patents before both European and U.S. courts.

Stephanie Garth
Regulatory Affairs Consultant
Linkedin

Ms. Garth has over 27 years of experience in the medical device industry and has been involved in over 90 successful 510(k) applications. She has experience with pre-IDEs, BLAs and international regulatory approvals. She currently serves as Director of QA/RA of clinical chemistry and immunoassay at Beckman Coulter Diagnostics.

Travis Garth
Quality Assurance Consultant
Linkedin

Mr. Garth has extensive experience in quality systems implementation, SOPs and document control systems. He is currently director at Global Compliance Plus.